Daptomycin-induced eosinophilic pneumonia - a systematic review-Reference-Cited by-同舟云学术

Daptomycin-induced eosinophilic pneumonia - a systematic review

Published:2016-12 Issue:1 Volume:5 Page:
ISSN:2047-2994
Container-title:Antimicrobial Resistance & Infection Control
language:en
Short-container-title:Antimicrob Resist Infect Control

Author:

Uppal Priyasha,LaPlante Kerry L.,Gaitanis Melissa M.,Jankowich Matthew D.,Ward Kristina E.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health

Link

http://link.springer.com/content/pdf/10.1186/s13756-016-0158-8.pdf

Reference46 articles.

1. Kim PW, Sorbello AF, Wassel RT, et al. Eosinophilic pneumonia in patients treated with daptomycin: review of the literature and US FDA adverse event reporting system records. Drug Saf. 2012;35:447–57.

2. US Food and Drug Administration. FDA drug safety communication: eosinophilic pneumonia associated with the use of Cubicin (daptomycin). http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm220273.htm . (Accessed 30 Nov 2016).

3. Allen JN. Drug-induced eosinophilic lung disease. Clin Chest Med. 2004;25:77–88.

4. Cubicin (daptomycin) package insert. Lexington, MA: Cubist Pharmaceuticals; 2006 May.

5. Silverman JA, Mortin LI, Vanpraagh AD, et al. Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact. J Infect Dis. 2005;191:2149–52.

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of High-Dose Daptomycin and Ceftriaxone for Cardiac Implantable Electronic Device Infections: A 10-Year Experience;Clinical Therapeutics;2024-08

2. Association between age and onset of daptomycin-induced adverse events using the U.S. food and drug administration adverse event reporting system;Journal of Infection and Chemotherapy;2024-08

3. Daptomycin eosinophilic pneumonia, a systematic review of the literature and case series;Infection;2024-07-19

4. A Case of Confusion in an Obese Patient Treated With Daptomycin: Neurotoxicity;Cureus;2024-06-12

5. Antibiotics daptomycin interacts with S protein of SARS-CoV-2 to promote cell invasion of Omicron (B1.1.529) pseudovirus;Virulence;2024-04-24